| 000 | 01793 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250511195155.0 | ||
| 264 | 0 | _c19920901 | |
| 008 | 199209s 0 0 eng d | ||
| 022 | _a0036-5548 | ||
| 024 | 7 |
_a10.3109/00365549209052612 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDofferhoff, A S | |
| 245 | 0 | 0 |
_aComplement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. _h[electronic resource] |
| 260 |
_bScandinavian journal of infectious diseases _c1992 |
||
| 300 |
_a197-204 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntithrombin III _xanalysis |
| 650 | 0 | 4 |
_aBacteremia _ximmunology |
| 650 | 0 | 4 |
_aBacterial Infections _ximmunology |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 | _aComplement Activation |
| 650 | 0 | 4 |
_aComplement C3a _xbiosynthesis |
| 650 | 0 | 4 |
_aComplement C3d _xbiosynthesis |
| 650 | 0 | 4 |
_aComplement C4 _xbiosynthesis |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 |
_aEndotoxins _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHemodynamics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 |
_aLactates _xblood |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlasminogen Inactivators _xblood |
| 650 | 0 | 4 |
_aShock, Septic _ximmunology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
| 700 | 1 | _ade Jong, H J | |
| 700 | 1 | _aBom, V J | |
| 700 | 1 | _avan der Meer, J | |
| 700 | 1 | _aLimburg, P C | |
| 700 | 1 | _ade Vries-Hospers, H G | |
| 700 | 1 | _aMarrink, J | |
| 700 | 1 | _aMulder, P O | |
| 700 | 1 | _aWeits, J | |
| 773 | 0 |
_tScandinavian journal of infectious diseases _gvol. 24 _gno. 2 _gp. 197-204 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/00365549209052612 _zAvailable from publisher's website |
| 999 |
_c1648075 _d1648075 |
||